CBD Life Sciences Inc. (OTCMKTS:CBDL) Sees Significant Decrease in Short Interest

CBD Life Sciences Inc. (OTCMKTS:CBDL) was the recipient of a large decline in short interest during the month of February. As of February 15th, there was short interest totalling 125,300 shares, a decline of 21.3% from the January 31st total of 159,300 shares. Based on an average daily volume of 41,278,100 shares, the days-to-cover ratio is currently 0.0 days.

CBD Life Sciences Price Performance

Shares of CBDL stock opened at $0.00 on Thursday. CBD Life Sciences has a 12 month low of $0.00 and a 12 month high of $0.03.

CBD Life Sciences Company Profile

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.